Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways

Presse Medicale · Published 2026-07-01 · DOI 10.1016/j.lpm.2026.104376

Free full text

Authors (10)

István Szondy, Katalin Martyin, Gabriella Mohos, Tara Kiss, Katalin Szabó, Mehdi Boostani, Mohamad Goldust, Andrzej Grzybowski, András Bánvölgyi, Norbert Kiss

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Szondy, I., Martyin, K., Mohos, G., et al. (2026). Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways. Presse Medicale. https://doi.org/10.1016/j.lpm.2026.104376

Related articles

• Toxic and explosive risks in pharmacy: an underestimated reality · Presse Medicale · 2026 · Same journal
• Albinism: from genetics to cell biology and physiopathology · Presse Medicale · 2025 · Same journal
• Immune checkpoint inhibitor-induced joint involvement · Presse Medicale · 2026 · Same journal
• Integrating AI into hospital workflows: Implementation strategies and real-world barriers · Presse Medicale · 2026 · Same journal
• Beyond one-size-fits-all: Personalising health communication to drive real behaviour change · Presse Medicale · 2026 · Same journal
• AI and longevity medicine: Unlocking predictive and preventive strategies for healthy aging · Presse Medicale · 2026 · Same journal
• Advice taking in medical decision making · Presse Medicale · 2026 · Same journal
• Albinism: Management and care of ophthalmological manifestations · Presse Medicale · 2025 · Same journal
• Metacognition and post-decisional processing in clinical decision-making · Presse Medicale · 2026 · Same journal
• Integrated care in COPD · Presse Medicale · 2025 · Same journal